country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-P992356

Copy Link Print Information

GENA-104A16

GENA-104A16 is a humanized monoclonal antibody targeting CNTN4, with multiple functions including immunostimulation, cytotoxicity and immunoregulation. By binding to CNTN4, GENA-104A16 blocks its interaction with APP, thereby restoring T cell function, inducing tumor cell death and regulating tumor-infiltrating immune cell populations. GENA-104A16 also exerts topoisomerase I inhibitory activity via the payload Exatecan (HY-13631). GENA-104A16 can be used in research related to colon cancer liver metastasis and other CNTN4-expressing solid tumors.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

GENA-104A16 Chemical Structure

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- Species Reactivity
- IC₅₀ & Target
- In Vitro
- In Vivo
- Gene ID
- Accession
- Target
- Conjugated
- Reconsititution
- Format
- 신청
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

Species Reactivity

Human

IC₅₀ & Target^[1]

Topoisomerase I

All Topoisomerase Isoforms :

In Vitro

GENA-104A16 potently kills CNTN4-positive cancer cells while exhibiting low Fcγ receptor-mediated cytotoxicity, an advantageous safety feature for antibody-drug conjugates^[1].
GENA-104A16 induces CNTN4-positive tumor cell death via multiple mechanisms and enhances T cell-mediated cytotoxicity through immune checkpoint blockade^[1].
GENA-104A16 increases T cell-mediated cytotoxicity against CNTN4-expressing human osteosarcoma U2OS cells in co-culture, with this effect dependent on CNTN4 expression by the cancer cells^[2].
GENA-104A16 restores T cell proliferation, activation, cytokine release, and cytotoxic killing activity against human CNTN4-expressing cancer cell lines^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

GENA-104A16 exerts anti-tumor and immune-modulatory effects in CT26/CNTN4 syngeneic mice, increasing total tumor-infiltrated immune cells 2-fold, CD4⁺ T cells 4-fold, and CD8⁺ T cells 1.5-fold while reducing Treg cell populations and restoring cytokine secretion^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Gene ID

152330 [NCBI]

Accession

Q8IWV2

Target

CNTN4

Conjugated

Unconjugated

Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.

Format

Product Image

신청

ELISA, FACS, Functional assay

Chemical Information

Formulation

Please refer to the lot-specific COA for specific buffer information.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Inhibitory Antibodies User Guide (603 KB)

References

[1]. Cha M Y, Yu H, Kim H, et al. Preclinical development of GENA-104 ADC, an exatecan-based novel antibody-drug conjugate targeting CNTN4, for solid tumors[J]. Cancer Research, 2026, 86(7_Supplement): 4443-4443.

[2]. Cha M Y, Yu H, Jeon B N, et al. Novel immune checkpoint inhibitor: In vivo and in vitro efficacy of anti-CNTN4 antibody, GENA-104A16 in the models with increased CNTN4 expression[J]. Cancer Research, 2023, 83(7_Supplement): 1868-1868.

[3]. Cha M Y, yu H, Jeon B N, et al. Novel immune checkpoint protein CNTN4 and the preclinical efficacy of affinity matured anti-CNTN4 antibody GENA-104A16[J]. Cancer Research, 2022, 82(12_Supplement): 2862-2862.

[4]. Cha M Y, Jeon B N, Kang H, et al. Activation of transcription factors, p65 and NFATc1, mediated by WNT5a, induces up-regulation of novel immune checkpoint CNTN4 expression[J]. Cancer Research, 2023, 83(7_Supplement): 6382-6382.

[5]. Yu H, Lee T, Kim G, et al. Immunostimulatory effects of GENA-104A16, a monoclonal anti-CNTN4 antibody, on tumor-infiltrating lymphocytes in a colon cancer liver metastasis model[J]. Cancer Research, 2025, 85(8_Supplement_1): 4790-4790.

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

견적 받기 해외재고보유

Amount: USD 0.00

Biological Activity
- 제품 설명
- Species Reactivity
- IC₅₀ & Target
- In Vitro
- In Vivo
- Gene ID
- Accession
- Target
- Conjugated
- Reconsititution
- Format
- 신청
Chemical Information
순도&문서
References

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

GENA-104A16

DPBS Buffer (1×)

Cytotoxicity LDH Assay Kit

PBS Buffer (1×)

All Topoisomerase Isoforms

Biological Activity

Chemical Information

순도&문서

References

Calculators

Help & FAQs

GENA-104A16 Related Classifications

HY-P992356 Related Classifications